Cargando…

Interplay between SARS-CoV-2 and the type I interferon response

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the current COVID-19 pandemic. An unbalanced immune response, characterized by a weak production of type I interferons (IFN-Is) and an exacerbated release of proinflammatory cytokines, contributes to the severe forms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sa Ribero, Margarida, Jouvenet, Nolwenn, Dreux, Marlène, Nisole, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390284/ https://www.ncbi.nlm.nih.gov/pubmed/32726355 http://dx.doi.org/10.1371/journal.ppat.1008737

Ejemplares similares

Clash of the titans: interferons and SARS-CoV-2
por: Jouvenet, Nolwenn, et al.
Publicado: (2021)

Evasion of Type I Interferon by SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2020)

Mosquito-borne flaviviruses and type I interferon: catch me if you can!
por: Zoladek, Jim, et al.
Publicado: (2023)

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons
por: Sinigaglia, Laura, et al.
Publicado: (2018)

Inhibition of SARS–CoV-2 by type I and type III interferons
por: Felgenhauer, Ulrike, et al.
Publicado: (2020)

Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
por: Chen, Xi, et al.
Publicado: (2021)

Activation and evasion of type I interferon responses by SARS-CoV-2
por: Lei, Xiaobo, et al.
Publicado: (2020)

Antiviral activities of type I interferons to SARS-CoV-2 infection
por: Mantlo, Emily, et al.
Publicado: (2020)

Type I interferons and SARS-CoV-2: from cells to organisms
por: Bastard, Paul, et al.
Publicado: (2022)

Type I and III interferon responses in SARS-CoV-2 infection
por: Kim, You-Me, et al.
Publicado: (2021)

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection
por: Mantlo, Emily, et al.
Publicado: (2020)

SARS-CoV-2 promote autophagy to suppress type I interferon response
por: Hui, Xianfeng, et al.
Publicado: (2021)

Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation
por: King, Cecile, et al.
Publicado: (2021)

Immune response in SARS-CoV-2 infection: the role of interferons type I and type III
por: Portela Sousa, Caciane, et al.
Publicado: (2020)

SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells
por: Rebendenne, Antoine, et al.
Publicado: (2021)

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen
por: Mac Kain, Alice, et al.
Publicado: (2022)

The Amino-Terminal Region of Hepatitis E Virus ORF1 Containing a Methyltransferase (Met) and a Papain-Like Cysteine Protease (PCP) Domain Counteracts Type I Interferon Response
por: Bagdassarian, Eugénie, et al.
Publicado: (2018)

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
por: Israelow, Benjamin, et al.
Publicado: (2020)

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
por: Israelow, Benjamin, et al.
Publicado: (2020)

Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication
por: Geerling, Elizabeth, et al.
Publicado: (2021)

Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
por: Bills, Cody J., et al.
Publicado: (2023)

SARS-CoV-2 and interferon blockade
por: Diamond, Betty, et al.
Publicado: (2020)

Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
por: Venet, Manon, et al.
Publicado: (2023)

Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
por: Banerjee, Arinjay, et al.
Publicado: (2021)

Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection
por: Nagaoka, Kentaro, et al.
Publicado: (2022)

Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
por: Shalamova, Lyudmila, et al.
Publicado: (2022)

ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads
por: Marchio, Agnès, et al.
Publicado: (2021)

The interplay of SARS-CoV-2 and Clostridioides difficile infection
por: Khanna, Sahil, et al.
Publicado: (2021)

Bidirectional interplay between SARS-CoV-2 and autophagy
por: Zhou, Hao, et al.
Publicado: (2023)

Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
por: Saccon, Elisa, et al.
Publicado: (2021)

The early interferon catches the SARS-CoV-2
por: Decker, Thomas
Publicado: (2021)

Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells
por: Aicher, Sophie-Marie, et al.
Publicado: (2022)

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
por: Jiang, He-wei, et al.
Publicado: (2020)

Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
por: Hatton, Catherine F., et al.
Publicado: (2021)

ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signaling
por: Wu, Beibei, et al.
Publicado: (2021)

Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022)

Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
por: Hoang, Timothy N., et al.
Publicado: (2022)

Type‐I Interferon assessment in 45 minutes using the FilmArray(®) PCR platform in SARS‐CoV‐2 and other viral infections
por: Mommert, Marine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fcos8v220stoh85qqa5qipm540